FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313857599> ?p ?o ?g. }

• W4313857599 endingPage "517" @default.
• W4313857599 startingPage "503" @default.
• W4313857599 abstract "Acquired aplastic anemia (AA) is a bone marrow failure disorder characterized by pancytopenia, and immunosuppressive therapy (IST) is the optional first-line management. Several studies identified the influencing factors on IST response; however, there are still a considerable number of patients suffering from poor prognoses. In this study, we enrolled 61 AA patients aged ≤ 40 years old, and whole-exome sequencing (WES) found unexpected high FANC heterozygous germline mutations (28/61, 45.9%). Patients with FANC mutations have a significantly lower absolute reticulocyte count and CD34+ % in the bone marrow and also lower 3-, 6-, and 9-month IST response than that without mutation, which were 0% vs. 25% (P = 0.017), 26.3% vs. 42.1% (P = 0.495), and 29.4% vs. 72.2% (P = 0.011), especially in anti-thymocyte globulin combined with the cyclosporin A (ATG + CsA) group, which were 0% vs.33.4% (P = 0.143), 25% vs.83.3% (P = 0.103), and 25% vs. 100% (P = 0.003), respectively. The event-free survival in the FANCwt group was also better than that in the FANCmut group (P = 0.016) and also showed in patients who received ATG + CsA treatment (P = 0.045). In addition, all the adverse effects of FANC germline mutation were not significant in stem cell-transplanted group. Our result indicated that the WES-based detection of FANC heterozygous germline mutations may have a great meaning in predicting IST response of acquired AA. This study was registered at chictr.org.cn (# ChiCTR2100054992)." @default.
• W4313857599 created "2023-01-10" @default.
• W4313857599 creator A5013352407 @default.
• W4313857599 creator A5015220079 @default.
• W4313857599 creator A5020935848 @default.
• W4313857599 creator A5022819702 @default.
• W4313857599 creator A5023501428 @default.
• W4313857599 creator A5028564740 @default.
• W4313857599 creator A5040558103 @default.
• W4313857599 creator A5040762883 @default.
• W4313857599 creator A5045307555 @default.
• W4313857599 creator A5048475468 @default.
• W4313857599 creator A5048750214 @default.
• W4313857599 creator A5055625945 @default.
• W4313857599 creator A5061160382 @default.
• W4313857599 creator A5064161818 @default.
• W4313857599 creator A5064760098 @default.
• W4313857599 creator A5077001594 @default.
• W4313857599 creator A5081012936 @default.
• W4313857599 creator A5082496274 @default.
• W4313857599 creator A5085028455 @default.
• W4313857599 creator A5088293516 @default.
• W4313857599 date "2023-01-09" @default.
• W4313857599 modified "2023-09-27" @default.
• W4313857599 title "Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study" @default.
• W4313857599 cites W1574365169 @default.
• W4313857599 cites W1742238700 @default.
• W4313857599 cites W1980740976 @default.
• W4313857599 cites W1984068087 @default.
• W4313857599 cites W2000067413 @default.
• W4313857599 cites W2000867649 @default.
• W4313857599 cites W2026050615 @default.
• W4313857599 cites W2051978340 @default.
• W4313857599 cites W2052285621 @default.
• W4313857599 cites W2059145105 @default.
• W4313857599 cites W2060862062 @default.
• W4313857599 cites W2076357933 @default.
• W4313857599 cites W2103441770 @default.
• W4313857599 cites W2104549677 @default.
• W4313857599 cites W2108234281 @default.
• W4313857599 cites W2128505445 @default.
• W4313857599 cites W2131799119 @default.
• W4313857599 cites W2155013511 @default.
• W4313857599 cites W2160995259 @default.
• W4313857599 cites W2166325770 @default.
• W4313857599 cites W2179672927 @default.
• W4313857599 cites W2180801403 @default.
• W4313857599 cites W2414838418 @default.
• W4313857599 cites W2460137265 @default.
• W4313857599 cites W2775719244 @default.
• W4313857599 cites W2784801005 @default.
• W4313857599 cites W2794284550 @default.
• W4313857599 cites W2800346446 @default.
• W4313857599 cites W2802531307 @default.
• W4313857599 cites W2811415793 @default.
• W4313857599 cites W2886591166 @default.
• W4313857599 cites W2946533487 @default.
• W4313857599 cites W2998964744 @default.
• W4313857599 cites W3001022860 @default.
• W4313857599 cites W3182263044 @default.
• W4313857599 cites W3190699003 @default.
• W4313857599 cites W3214569081 @default.
• W4313857599 cites W4242467593 @default.
• W4313857599 cites W783150221 @default.
• W4313857599 doi "https://doi.org/10.1007/s00277-023-05086-9" @default.
• W4313857599 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36622392" @default.
• W4313857599 hasPublicationYear "2023" @default.
• W4313857599 type Work @default.
• W4313857599 citedByCount "0" @default.
• W4313857599 crossrefType "journal-article" @default.
• W4313857599 hasAuthorship W4313857599A5013352407 @default.
• W4313857599 hasAuthorship W4313857599A5015220079 @default.
• W4313857599 hasAuthorship W4313857599A5020935848 @default.
• W4313857599 hasAuthorship W4313857599A5022819702 @default.
• W4313857599 hasAuthorship W4313857599A5023501428 @default.
• W4313857599 hasAuthorship W4313857599A5028564740 @default.
• W4313857599 hasAuthorship W4313857599A5040558103 @default.
• W4313857599 hasAuthorship W4313857599A5040762883 @default.
• W4313857599 hasAuthorship W4313857599A5045307555 @default.
• W4313857599 hasAuthorship W4313857599A5048475468 @default.
• W4313857599 hasAuthorship W4313857599A5048750214 @default.
• W4313857599 hasAuthorship W4313857599A5055625945 @default.
• W4313857599 hasAuthorship W4313857599A5061160382 @default.
• W4313857599 hasAuthorship W4313857599A5064161818 @default.
• W4313857599 hasAuthorship W4313857599A5064760098 @default.
• W4313857599 hasAuthorship W4313857599A5077001594 @default.
• W4313857599 hasAuthorship W4313857599A5081012936 @default.
• W4313857599 hasAuthorship W4313857599A5082496274 @default.
• W4313857599 hasAuthorship W4313857599A5085028455 @default.
• W4313857599 hasAuthorship W4313857599A5088293516 @default.
• W4313857599 hasBestOaLocation W43138575991 @default.
• W4313857599 hasConcept C104317684 @default.
• W4313857599 hasConcept C109159458 @default.
• W4313857599 hasConcept C109825262 @default.
• W4313857599 hasConcept C126322002 @default.
• W4313857599 hasConcept C13514818 @default.
• W4313857599 hasConcept C16671776 @default.
• W4313857599 hasConcept C194409129 @default.

• next